Icaritin inhibited cigarette smoke extract-induced CD8+ T cell chemotaxis enhancement by targeting the CXCL10/CXCR3 axis and TGF-β/Smad2 signaling

被引:8
|
作者
Li, Qiuping [1 ,2 ]
Sun, Jing [1 ,3 ]
Cao, Yuxue [1 ]
Liu, Baojun [1 ]
Zhao, Zhengxiao [1 ]
Hu, Lingli [1 ]
Zhang, Hu [1 ]
Kong, Qing [1 ]
Wu, Jinfeng [1 ,4 ]
Dong, Jingcheng [1 ,3 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Integrat Med, Shanghai 200040, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Prov Geriatr Inst, Guangzhou 510080, Peoples R China
[3] Fudan Univ, Inst Integrat Med, Shanghai 200040, Peoples R China
[4] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200040, Peoples R China
基金
中国国家自然科学基金;
关键词
Icaritin; Cigarette smoke extract; CXCL10/CXCR3; CD8+T cells; chemotaxis; ATTRACTION; ACTIVATION; MEDIATORS; CANCER; CXCR3;
D O I
10.1016/j.phymed.2021.153907
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Chronic obstructive pulmonary disease (COPD) is a disabling/fatal disease characterized by progressive pulmonary function decline, and there are currently few drugs that can effectively reverse the decline in lung function; therefore, it is necessary to find novel drug targets. CD8+ T cells might be a new therapeutic target for alleviating lung tissue destruction and improving pulmonary function in COPD. The CXCL10/CXCR3 axis is a pivotal chemotactic axis involved in the abnormal infiltration of CD8+ T cells into the lung tissue of COPD; thus, inhibition of this axis might be a potential method to suppress CD8+ T cell-mediated lung tissue destruction in COPD. However, few drugs have been reported to target CD8+ T cells and the CXCL10/CXCR3 axis. Icaritin (ICT), one of the major components of Epimedii Folium, has been reported to have antioxidative effects in a COPD model in vitro. Whether ICT also has effects on CD8+ T cells and the CXCL10/CXCR3 axis in COPD has never been investigated. Purpose: This study aimed to investigate the effects of ICT on CD8+ T cell chemotaxis and the CXCL10/CXCR3 axis in interferon (IFN)-gamma + cigarette smoke extract (CSE)-stimulated THP-1-derived macrophages, which simulated the pulmonary microenvironment of COPD, and then to determine the mechanisms. Methods: The effects of ICT on the expression and secretion of CXCL9, CXCL10, and CXCL11 in THP-1-derived macrophages were measured by qRT-PCR and ELISA, and the effects of the supernatant of THP-1-derived macrophages treated with or without ICT on CD8+ T cell chemotaxis were also evaluated. Subsequently, the effects of ICT on the apoptosis and proliferation of CD8+ T cells were also assessed by EdU-488 assays and Annexin V/PI staining, respectively. Moreover, the mechanisms by which ICT inhibits the CXCL10/CXCR3 axis were investigated by RNA sequencing (RNA-seq) and KEGG pathway enrichment analysis. Results: The present study showed that ICT (5 mu M) significantly suppressed the expression and secretion of CXCL9, CXCL10, and CXCL11 in THP-1-derived macrophages after stimulation with IFN-gamma + CSE and indirectly inhibited CD8+ T cell chemotaxis by reducing the secretion of the above chemokines. In addition, this study found that ICT had no significant effect on the proliferation of CD8+ T cells, and neither led to apoptosis. The results of the RNA-seq analysis illustrated that the transforming growth factor (TGF)-beta signaling pathway was significantly downregulated after ICT intervention, and subsequent qRT-PCR and western blotting showed that ICT could significantly downregulate the TGF-beta-Smad2 signaling pathway. Conclusions: ICT reduced CD8+ T cell chemotaxis by inhibiting the CXCL10/CXCR3 axis, and these effects might be achieved by suppressing the TGF-beta-Smad2 signaling pathway.
引用
收藏
页数:10
相关论文
共 8 条
  • [1] STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis
    Yue, Chanyu
    Shen, Shudan
    Deng, Jiehui
    Priceman, Saul J.
    Li, Wenzhao
    Huang, Austin
    Yu, Hua
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (08) : 864 - 870
  • [2] CXCR3/CXCL10 Axis Shapes Tissue Distribution of Memory Phenotype CD8+ T Cells in Nonimmunized Mice
    Alanio, Cecile
    da Silva, Rosa Barreira
    Michonneau, David
    Bousso, Philippe
    Ingersoll, Molly A.
    Albert, Matthew L.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01): : 139 - 146
  • [3] CXCL4/CXCR3 axis regulates cardiac fibrosis by activating TGF-β1/Smad2/3 signaling in mouse viral myocarditis
    Wei, Jing
    Wang, Dan-feng
    Cui, Cong-cong
    Tan, Jia-jia
    Peng, Ming-yu
    Lu, Hong-xiang
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (04)
  • [4] SB431542 inhibited cigarette smoke extract induced invasiveness of A549 cells via the TGF-β1/Smad2/MMP3 pathway
    Liao, Ke
    Yong, Chen-Wei
    Hua, Ke
    ONCOLOGY LETTERS, 2018, 15 (06) : 9681 - 9686
  • [5] LINC00152 mediates CD8+ T-cell infiltration in gastric cancer through binding to EZH2 and regulating the CXCL9, 10/CXCR3 axis
    Jinqing Ou
    Pingguang Lei
    Zhenling Yang
    Man Yang
    Lingmin Luo
    Hongdan Mo
    Guijin Luo
    Junhui He
    Journal of Molecular Histology, 2021, 52 : 611 - 620
  • [6] LINC00152 mediates CD8+ T-cell infiltration in gastric cancer through binding to EZH2 and regulating the CXCL9, 10/CXCR3 axis
    Ou, Jinqing
    Lei, Pingguang
    Yang, Zhenling
    Yang, Man
    Luo, Lingmin
    Mo, Hongdan
    Luo, Guijin
    He, Junhui
    JOURNAL OF MOLECULAR HISTOLOGY, 2021, 52 (03) : 611 - 620
  • [7] CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity
    Chiu, Tsu-Man
    Chen, Chun-Bing
    Lu, Chun-Wei
    Hui, Rosaline Chung-Yee
    Chi, Min-Hui
    Chang, Ya-Ching
    Wu, Jennifer
    Chen, Kuan-Yu
    Lin, Yang Yu-Wei
    Lo, Pei-Chi
    Hsu, Tsai-Ching
    Wang, Chuang-Wei
    Chung, Wen-Hung
    BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [8] Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophages
    Hart, Martin
    Nickl, Laura
    Walch-Rueckheim, Barbara
    Krammes, Lena
    Rheinheimer, Stefanie
    Diener, Caroline
    Taenzer, Tanja
    Kehl, Tim
    Sester, Martina
    Lenhof, Hans-Peter
    Keller, Andreas
    Meese, Eckart
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)